The presentation of the results of the study of secondary metabolite production in actinomycetes.

Provider

Ministry of Education, Youth and Sports

Programme

—

Call for proposals

—

Main participants

Mikrobiologický ústav AV ČR, v. v. i.

Contest type

—

Contract ID

—

Project name in Czech

Prezentace výsledků studia produkce sekundárních metabolitů u aktinomycet.

Annotation in Czech

Vřsledky studia produkce sekundßrnÝch metabolit¨ u aktinomycet budou prezentovßny ve formý p°ednßÜky a plakßtovřch sdýlenÝ na 11. mezinßrodnÝm sympoziu biologie aktinomycet (11th ISBA, 24.10. - 28.10. 1999, Sissi - Heraklion, ěecko). P°edklßdanÚ prßce budou zahrnovat: - Studium fyziologie a genetiky produkce linkomycinu, vřznamnÚho antibiotika u×ÝvanÚho v humßnnÝ medicÝný, konkrÚtný identifikaci jednotlivřch gen¨ linkomycinovÚho shluku, ˙ŔastnÝcÝch se poslednÝch krok¨ biosyntÚzy linkomycinu (kondenzace,N-methylace) u Streptomyces lincolnensis. - Studium regulace transkripce u streptomycet a konkrÚtnÝ funkce jednotlivřch forem DNA dependentnÝ RNA polymerßzy v r¨znřch stßdiÝch vřvoje bu˛ky.

R&D category

—

CEP classification - main branch

EE - Microbiology, virology

CEP - secondary branch

EB - Genetics and molecular biology

CEP - another secondary branch

EI - Biotechnology and bionics

OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10606 - Microbiology<br>10607 - Virology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30101 - Human genetics<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics

Provider evaluation

U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

Project results evaluation

Zaslßna pr¨bý×nß zprßva o °eÜenÝ projektu v roce 1998vŔetný podrobnÚho zd¨vodnýnÝ Ŕerpanřch finanŔnÝch prost°edk¨ na °eÜenÝ projektu v roce 1998

Realization period - beginning

Jan 1, 1999

Realization period - end

Jan 1, 1999

Project status

U - Finished project

Latest support payment

—

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data delivery code

CEP/2000/MSM/MSM0PG/U/6:3

Data delivery date

—

Total approved costs

135 thou. CZK

Public financial support

67 thou. CZK

Other public sources

0 thou. CZK

Non public and foreign sources

0 thou. CZK